Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. today announced the completion of patient enrollment in the TACT (TULSA-PRO® Ablation Clinical Trial) pivotal study... Read more
FloSonics Medical Secures $5 Million Seed Round Funding
SUDBURY ON — Jan. 29, 2018 — FloSonics Medical, a Canadian medical device company headquartered in Greater Sudbury, Ontario, has secured $5 million in a funding round... Read more